HUP9900751A3 - Stable pharmaceutical forms of administration containing parathormone - Google Patents

Stable pharmaceutical forms of administration containing parathormone

Info

Publication number
HUP9900751A3
HUP9900751A3 HU9900751A HUP9900751A HUP9900751A3 HU P9900751 A3 HUP9900751 A3 HU P9900751A3 HU 9900751 A HU9900751 A HU 9900751A HU P9900751 A HUP9900751 A HU P9900751A HU P9900751 A3 HUP9900751 A3 HU P9900751A3
Authority
HU
Hungary
Prior art keywords
parathormone
pharmaceutical forms
stable pharmaceutical
administration containing
administration
Prior art date
Application number
HU9900751A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of HUP9900751A2 publication Critical patent/HUP9900751A2/hu
Publication of HUP9900751A3 publication Critical patent/HUP9900751A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9900751A 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone HUP9900751A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19538687A DE19538687A1 (de) 1995-10-17 1995-10-17 Stabile pharmazeutische Darreichungsformen enthaltend Parathormon

Publications (2)

Publication Number Publication Date
HUP9900751A2 HUP9900751A2 (hu) 1999-07-28
HUP9900751A3 true HUP9900751A3 (en) 2000-07-28

Family

ID=7775105

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900751A HUP9900751A3 (en) 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone

Country Status (14)

Country Link
EP (1) EP0855917A1 (cs)
JP (1) JPH11515002A (cs)
KR (1) KR19990064322A (cs)
AU (1) AU7294196A (cs)
BR (1) BR9610983A (cs)
CA (1) CA2234724A1 (cs)
CZ (1) CZ108398A3 (cs)
DE (1) DE19538687A1 (cs)
HU (1) HUP9900751A3 (cs)
NZ (1) NZ320237A (cs)
SK (1) SK47298A3 (cs)
TR (1) TR199800690T1 (cs)
WO (1) WO1997014429A1 (cs)
ZA (1) ZA968715B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
DE19716154A1 (de) * 1997-04-18 1998-10-22 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsform für Peptide, Proteine und Nukleinsäuren
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
ZA9811127B (en) † 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
AU1189301A (en) * 1999-10-29 2001-05-14 Eli Lilly And Company A pharmaceutical composition having high cell membrane permeability
DK1398038T4 (da) * 2000-02-08 2011-03-28 Allergan Inc Lægemidler med botulinustoxin
NZ523457A (en) * 2000-06-30 2004-11-26 Daiichi Suntory Pharma Co Composition for stimulating bone formation comprising hPTH in which the acetic acid component is low enough for administration to the nasal mucosa
KR101235507B1 (ko) * 2003-02-28 2013-02-20 추가이 세이야쿠 가부시키가이샤 단백질을 함유하는 안정화 제제
WO2005014034A1 (en) * 2003-07-14 2005-02-17 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
KR100700869B1 (ko) * 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 Ｐｔｈ, 완충제 및 안정제를 포함하는 안정한 ｐｔｈ조성물
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
FR2947181B1 (fr) * 2009-06-26 2012-05-04 Lfb Biotechnologies Composition de facteur vii
KR20150116467A (ko) 2011-06-07 2015-10-15 아사히 가세이 파마 가부시키가이샤 고순도 ｐｔｈ 함유 동결 건조 제제 및 그의 제조 방법
ES3055185T3 (en) 2014-03-28 2026-02-10 Univ Duke Treatment of an estrogen receptor positive breast cancer using a selective estrogen receptor modulator
KR20250152679A (ko) 2015-04-29 2025-10-23 래디어스 파마슈티컬스, 인코포레이티드 암을 치료하는 방법
JP6634758B2 (ja) * 2015-09-25 2020-01-22 ニプロ株式会社 液体組成物及び凍結乾燥製剤
JP7481115B2 (ja) 2017-01-05 2024-05-10 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形性形態
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
US20200289621A1 (en) * 2017-09-22 2020-09-17 Asahi Kasei Pharma Corporation Teriparatide-containing liquid pharmaceutical composition having excellent stability
MX2020013713A (es) 2018-07-04 2021-03-02 Radius Pharmaceuticals Inc Formas polimorficas de rad1901-2hcl.
EP3924328A1 (en) 2019-02-12 2021-12-22 Radius Pharmaceuticals, Inc. Processes and compounds
WO2021229835A1 (ja) * 2020-05-11 2021-11-18 旭化成ファーマ株式会社 テリパラチド又はその塩を含有する安定な液状医薬製剤
JP6947946B1 (ja) * 2020-05-11 2021-10-13 旭化成ファーマ株式会社 テリパラチド又はその塩を含有する安定な液状医薬製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
JP2739482B2 (ja) * 1988-08-11 1998-04-15 バイオ・チバ株式会社 安定なカルシトニン注射液の製造方法
JPH0341033A (ja) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd 安定なモチリン類含有製剤
ES2129048T3 (es) * 1991-12-09 1999-06-01 Asahi Chemical Ind Composicion estabilizada de hormona paratiroide.
DE4203040A1 (de) * 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
AU7294196A (en) 1997-05-07
HUP9900751A2 (hu) 1999-07-28
KR19990064322A (ko) 1999-07-26
ZA968715B (en) 1998-04-16
DE19538687A1 (de) 1997-04-24
EP0855917A1 (de) 1998-08-05
JPH11515002A (ja) 1999-12-21
CZ108398A3 (cs) 1998-09-16
BR9610983A (pt) 1999-03-02
WO1997014429A1 (de) 1997-04-24
TR199800690T1 (xx) 1998-06-22
CA2234724A1 (en) 1997-04-24
NZ320237A (en) 1999-11-29
SK47298A3 (en) 1998-11-04

Similar Documents

Publication Publication Date Title
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
PL312064A1 (en) Soft gelatinous form of pharmaceutical dose
IL117265A (en) Benzazepine- benzoxazepine- and benzothiazepine-N-acetic acid derivatives their preparation and pharmaceutical compositions containing them
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL117193A0 (en) Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them
IL117041A0 (en) Oral pharmaceutical dosage form
HUP9801749A3 (en) Nodulisporic acid derivatives and pharmaceutical compositions containing them
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
GB9700737D0 (en) Administration of drugs
IL115125A0 (en) Pharmaceutical formulations comprising derivatives of clavulanic acid
HU9500386D0 (en) Benzodiazepine derivatives and pharmaceutical compositions containing them
AU1766592A (en) Pharmaceutical formulations of a benzodiazepine
ZA964517B (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
IL116910A0 (en) Novel pharmaceutical formulation for topical administration
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them
IL117152A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation and use of pharmaceutical preparation based on these compounds and medicaments containing them
AU5560694A (en) Pharmaceutical formulations of ibuprofen
IL123000A (en) Aza-anthracylinone derivatives their preparation and pharmaceutical compositions containing them
GB9304745D0 (en) Use of pharmaceutical formulations
HUP9602220A2 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
IL122652A (en) Polymorphs of the pro drug 6-n-(l-ala-l-ala)- trovafloxacin their preparation and pharmaceutical compositions containing them
GB9304549D0 (en) Apparatus for administration of drugs